Identification of molecular determinants from Moloney leukemia virus 10 homolog (MOV10) protein for virion packaging and anti-HIV-1 activity

Journal of Biological Chemistry

Volumn 287, Issue 2, 2012, Pages 1220-1228

  Abudu, Aierken ^a   Wang, Xiaojun ^a,b   Dang, Ying ^a   Zhou, Tao ^a   Xiang, Shi Hua ^c   Zheng, Yong Hui ^a  

^a Michigan State University ^*  (United States)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c UNIVERSITY OF NEBRASKA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-HIV-1 ACTIVITY; ANTIRETROVIRALS; ANTIVIRAL ACTIVITIES; C TERMINUS; CRITICAL DETERMINANT; ECTOPIC EXPRESSIONS; HELICASES; MOLECULAR BASIS; MOLECULAR DETERMINANTS; N-TERMINALS; NUCLEOCAPSIDS; RNA HELICASES; THREE-DIMENSIONAL STRUCTURE; VIRAL REPLICATION;

AMINO ACIDS; PACKAGING; RNA; THREE DIMENSIONAL; VIRUSES;

DISEASES;

AMINO ACID; GAG PROTEIN; HELICASE; MOLONEY LEUKEMIA ONCOVIRUS 10 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA PACKAGING; ENZYME STRUCTURE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION CONTROL; MOLECULAR DYNAMICS; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; VIRION;

AMINO ACID MOTIFS; CELL LINE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-1; HUMANS; MODELS, MOLECULAR; NUCLEOCAPSID; PEPTIDE MAPPING; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RNA HELICASES; VIRUS ASSEMBLY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MOLONEY MURINE LEUKEMIA VIRUS;

EID: 84862925208     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.309831     Document Type: Article

References (32)

1. Mooslehner, K., Müller, U., Karls, U., Hamann, L., and Harbers, K. (1991) Structure and expression of a gene encoding a putative GTP-binding protein identified by provirus integration in a transgenic mouse strain. Mol. Cell. Biol. 11, 886-893 (Pubitemid 21895437)
2. Koonin, E. V. (1992) Trends Biochem. Sci. 17, 495-497
3. Jeang, K. T., and Yedavalli, V. (2006) Role of RNA helicases in HIV-1 replication. Nucleic Acids Res. 34, 4198-4205
4. Chendrimada, T. P., Finn, K. J., Ji, X., Baillat, D., Gregory, R. I., Liebhaber, S. A., Pasquinelli, A. E., and Shiekhattar, R. (2007) MicroRNA silencing through RISC recruitment of eIF6. Nature 447, 823-828 (Pubitemid 46920131)
5. Meister, G., Landthaler, M., Peters, L., Chen, P. Y., Urlaub, H., Lührmann, R., and Tuschl, T. (2005) Identification of novel argonaute-associated proteins. Curr. Biol. 15, 2149-2155 (Pubitemid 41739749)
6. Burdick, R., Smith, J. L., Chaipan, C., Friew, Y., Chen, J., Venkatachari, N. J., Delviks-Frankenberry, K. A., Hu, W. S., and Pathak, V. K. (2010) P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages. J. Virol. 84, 10241-10253
7. Furtak, V., Mulky, A., Rawlings, S. A., Kozhaya, L., Lee, K., Kewalramani, V. N., and Unutmaz, D. (2010) Perturbation of the P body component Mov10 inhibits HIV-1 infectivity. PLoS One 5, e9081
8. Wang, X., Han, Y., Dang, Y., Fu, W., Zhou, T., Ptak, R. G., and Zheng, Y. H. (2010) Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication. J. Biol. Chem. 285, 14346-14355
9. Zheng, Y. H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., and Peterlin, B. M. (2004) Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication. J. Virol. 78, 6073-6076 (Pubitemid 38661697)
10. Burnett, A., and Spearman, P. (2007) APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker. J. Virol. 81, 5000-5013 (Pubitemid 46744412)
11. Derdowski, A., Ding, L., and Spearman, P. (2004) A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions. J. Virol. 78, 1230-1242 (Pubitemid 38095833)
12. Clerici, M., Mourão, A., Gutsche, I., Gehring, N. H., Hentze, M. W., Kulozik, A., Kadlec, J., Sattler, M., and Cusack, S. (2009) Unusual bipartite mode of interaction between the nonsense-mediated decay factors, UPF1 and UPF2. EMBO J. 28, 2293-2306
13. Chertova, E., Chertov, O., Coren, L. V., Roser, J. D., Trubey, C. M., Bess, J. W., Jr., Sowder, R. C., 2nd, Barsov, E., Hood, B. L., Fisher, R. J., Nagashima, K., Conrads, T. P., Veenstra, T. D., Lifson, J. D., and Ott, D. E. (2006) Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 80, 9039-9052 (Pubitemid 44359978)
14. Huang, Y., Kong, W. P., and Nabel, G. J. (2001) Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression. J. Virol. 75, 4947-4951 (Pubitemid 32381541)
15. Cen, S., Guo, F., Niu, M., Saadatmand, J., Deflassieux, J., and Kleiman, L. (2004) The interaction between HIV-1 Gag and APOBEC3G. J. Biol. Chem. 279, 33177-33184 (Pubitemid 39062962)
16. Luo, K., Liu, B., Xiao, Z., Yu, Y., Yu, X., Gorelick, R., and Yu, X. F. (2004) Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging. J. Virol. 78, 11841-11852 (Pubitemid 39390771)
17. Schäfer, A., Bogerd, H. P., and Cullen, B. R. (2004) Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the Gag polyprotein precursor. Virology 328, 163-168 (Pubitemid 39349465)
18. Svarovskaia, E. S., Xu, H., Mbisa, J. L., Barr, R., Gorelick, R. J., Ono, A., Freed, E. O., Hu, W. S., and Pathak, V. K. (2004) Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs. J. Biol. Chem. 279, 35822-35828 (Pubitemid 39100589)
19. Zennou, V., Perez-Caballero, D., Göttlinger, H., and Bieniasz, P. D. (2004) APOBEC3G incorporation into human immunodeficiency virus type 1 particles. J. Virol. 78, 12058-12061 (Pubitemid 39390791)
20. Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H., and Landau, N. R. (2003) Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114, 21-31 (Pubitemid 36859838)
21. Marin, M., Rose, K. M., Kozak, S. L., and Kabat, D. (2003) HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9, 1398-1403 (Pubitemid 37466189)
22. Sheehy, A. M., Gaddis, N. C., and Malim, M. H. (2003) The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9, 1404-1407 (Pubitemid 37466190)
23. Stopak, K., de Noronha, C., Yonemoto, W., and Greene, W. C. (2003) HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol. Cell 12, 591-601 (Pubitemid 37222482)
24. Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., and Yu, X. F. (2003) Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060 (Pubitemid 37386201)
25. Chiu, Y. L., Witkowska, H. E., Hall, S. C., Santiago, M., Soros, V. B., Esnault, C., Heidmann, T., and Greene, W. C. (2006) High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc. Natl. Acad. Sci. U.S.A. 103, 15588-15593 (Pubitemid 44625636)
26. Gallois-Montbrun, S., Kramer, B., Swanson, C. M., Byers, H., Lynham, S., Ward, M., and Malim, M. H. (2007) Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J. Virol. 81, 2165-2178
27. Kozak, S. L., Marin, M., Rose, K. M., Bystrom, C., and Kabat, D. (2006) The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J. Biol. Chem. 281, 29105-29119 (Pubitemid 44507054)
28. Heise, C. T., Le Duff, C. S., Boter, M., Casais, C., Airey, J. E., Leech, A. P., Amigues, B., Guerois, R., Moore, G. R., Shirasu, K., and Kleanthous, C. (2007) Biochemical characterization of RAR1 cysteine- and histidine-rich domains (CHORDs): a novel class of zinc-dependent protein-protein interaction modules. Biochemistry 46, 1612-1623
29. Kadlec, J., Guilligay, D., Ravelli, R. B., and Cusack, S. (2006) Crystal structure of the UPF2-interacting domain of nonsense-mediated mRNA decay factor UPF1. RNA 12, 1817-1824 (Pubitemid 44484255)
30. Huthoff, H., and Malim, M. H. (2007) Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and virion encapsidation. J. Virol. 81, 3807-3815 (Pubitemid 46586878)
31. Garrus, J. E., von Schwedler, U. K., Pornillos, O. W., Morham, S. G., Zavitz, K. H., Wang, H. E., Wettstein, D. A., Stray, K. M., Côté, M., Rich, R. L., Myszka, D. G., and Sundquist, W. I. (2001) Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107, 55-65 (Pubitemid 32972037)
32. Caruthers, J. M., and McKay, D. B. (2002) Helicase structure and mechanism. Curr. Opin. Struct. Biol. 12, 123-133 (Pubitemid 34142730)